Drawing for CARMS

USPTO serial 79409996

CARMS

Reviewed by CopyMark Law Group

Reg. 8007086Status 700Registered
Filing date
Status date
Registration date
Nov 4, 2025
Examiner
GARDNER, DAWNA BERYL
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CARMS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sarah Matthews

Sarah Matthews DENTONS DURHAM JONES PINEGAR1557 W. Innovation Way, STE 400Lehi, UT 84043United States

Goods and services

ClassDescriptionStatusFirst use
009Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; scientific apparatus and instruments, namely, fluid handling device used for disposable bioprocessing applications and parts and fitting therefor; apparatus for scientific research in laboratories, namely, scientific laboratory instruments for detecting pathogens; scientific, research and laboratory apparatus, namely, flow cytometers and flow-based analyzers providing cell and particle analysis, detection or counting; laboratory apparatus and instruments, namely, medical laboratory research instruments for thermal imaging; instruments for scientific research in laboratories, namely, laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; laboratory instruments for scientific research, namely, scientific laboratory instruments for detecting pathogens; scientific instruments, namely, electronic analyzers for measuring, testing and detecting contaminants and environmental pollutants; scientific apparatus, namely, optical mirrors; apparatus and instruments for research use, namely, scientific laboratory instruments for detecting pathogens; laboratory apparatus and instruments for scientific research, namely, scientific laboratory instruments for detecting pathogens; research apparatus and instruments, namely, medical laboratory research instruments for thermal imaging; apparatus and instruments for research purposes, namely scientific laboratory instruments for detecting pathogensACTIVE—
010Medical instruments, namely, diagnostic apparatus for analyzing and testing cell cultures and organoids; medical instruments for analyzing and testing bacteria.ACTIVE—
042Scientific research services in the field of bacteriology, namely, isolation and cultivation of bacterial cells; pharmaceutical research services; scientific research relating to molecular sciences; medical research and development in the field of molecular biology; medical research services; medical research laboratory services; biomedical research services; research in the field of science; testing of human tissues and stem cells for scientific research purposes; analysis of human tissues and stem cells for scientific research purposes; scientific research and analysis in the field of biological research and analysis; scientific research for medical purposes; scientific research and analysis services, namely, biological research and analysis; advisory services relating to scientific research; scientific research; pharmaceutical drug development services; drug discovery services; pharmaceutical research and development; pharmaceutical research and development, namely, development of pharmaceuticals; pharmaceutical research and development, namely, development of pharmaceutical preparations and medicines; scientific research and development for the pharmaceutical industry; scientific research and development; scientific and medical research and development; research to develop new products; conducting early evaluations in the field of new pharmaceuticals; research and development services of new pharmaceutical products; research in the field of pharmaceuticals; scientific research and development services for the pharmaceutical industry; biochemical research and development; laboratory research in the field of pharmaceuticals; scientific research in the field of pharmacogenomics; research and development services in the field of pharmaceutical preparations; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about medical and scientific research in the field of pharmaceuticals; product development consultancy for inventors in the field of molecular biology; research and development in the field of biochemistry * ; all the above-mentioned services exclude services related to scientific research in the field of climate change, climate action, equity, sustainability, economic diversification and energy system transition, climate action management *ACTIVE—
044Medical analysis services for the diagnosis and treatment of persons; pharmaceutical advice; providing information relating to drugs, namely, providing information relating to diagnostic, prophylactic and therapeutic property of pharmaceuticals; advisory services relating to drugs, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical interactionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 9, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Jun 4, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 18, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 18, 2026FIMPFINAL DISPOSITION PROCESSED—
May 18, 2026LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
May 16, 2026COC.CORRECTION UNDER SECTION 7 - PROCESSED—
May 16, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 7, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 20, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 20, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 4, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 4, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 4, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 16, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 16, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 10, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 17, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Aug 17, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 17, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 17, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 12, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 12, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 12, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 2, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 2, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 2, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 4, 2025LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Feb 15, 2025RFNTREFUSAL PROCESSED BY IB—
Jan 29, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 29, 2025RFRRREFUSAL PROCESSED BY MPU—
Dec 29, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 28, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 27, 2024DOCKASSIGNED TO EXAMINER—
Nov 22, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 22, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 21, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance